Posttranslational modification by glycation is another mechanism producing dysfunctional HDLCKD, especially when CKD is associated with diabetes, which further reduces LCAT cholesterol esterification and PON1 levels [49]. The gene discussed is PON1; the disease is chronic kidney disease.